VC
BVS icon

VarCov Co’s Bioventus BVS Stock Holding History

VarCov Co’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Sell
53,541
-4,035
-7% -$38.5K 0.19% 188
2026
Q1 		$526K Buy
+57,576
New +$483K 0.2% 195

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VarCov Co's BVS Position: Q2 2026 in Review

VarCov Co reduced its Bioventus (BVS) stake by 7% in Q2 2026, selling an estimated $38.5K and leaving 53,541 shares worth $505K. The position accounts for 0.19% of the portfolio, ranked #188.

VarCov Co first reported a position in BVS in Q1 2026 and has held it in 2 quarters since. The position peaked at $526K in Q1 2026. 156 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • VarCov Co held 53,541 shares of Bioventus worth $505K as of Q2 2026.
  • VarCov Co sold 4,035 Bioventus shares in Q2 2026, an estimated $38.5K.
  • Bioventus made up 0.19% of VarCov Co's portfolio in Q2 2026, its #188 holding.
  • VarCov Co first reported a position in Bioventus in Q1 2026 and has held it in 2 quarters since.
  • VarCov Co's Bioventus position peaked at $526K in Q1 2026.
  • 156 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.